EU-Compliant Batch Release of Medicinal Products How to Meet the Requirements of Annex 16 of the EU GMP Guide
The EU is very clear in its requirements for batch release… from training personnel to certify that each batch is exactly as it should be… to handling deviations in batches and dealing with shipping and imported products.
Annex 16 sets the rules for testing, certifying and releasing batches. It lays out the requirements for the role of the qualified person responsible for approving the release of every batch. But those broad strokes break into detailed processes and requirements that can be hard to interpret and even harder to follow.
EU-Compliant Batch Release of Medicinal Products: How to Meet the Requirements of Annex 16 of the EU GMP Guide, written by EMA and GMP inspector Rainer Gnibl, walks you step-by-step through the batch release process:
Relevant steps for creating a batch release SOP
Requirements for continuous training of the qualified person
Interpretations and excerpts of the guidelines
The report covers critical elements of the product and process flow, strategies and tools a qualified person can use to manage supply chain, import, technical agreements and delegation.
Key Report Highlights:
Steps involved in EU-compliant batch release of medicinal products
Requirements that must be met
Requirements applied to imported products
Responsibilities of the certifying qualified person and how to fulfill them
Support systems available to the qualified person
Responsibilities the certifying qualified person has for products fully or partially manufactured by contract manufacturers
Ways the certifying qualified person can meet the challenges of a complex global product/process flow
Avoid missteps and delays in getting your products to market in the EU. Order your copy today.
Order Your Copy Today
PDF Edition — $135
About the Author
As GMP Inspector for the Government of Upper Bavaria and the European Medicines Agency (EMA), Rainer Gnibl is responsible for carrying out national and international inspections of the manufacturers of medicinal products and active ingredients He is head of the national expert group EFG 02 “GMP inspections/GMP guidelines” and lectures at the Friedrich-Alexander University in Erlangen-Nurnberg.
Who Will Benefit
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.